New collaboration for real world evidence

Real World Evidence (RWE) is an emerging powerful trend that has the potential to redefine the basis of value-based pricing, competition and access in the near future. In response to the growing demand, we have joined forces with Dendrite Clinical Systems to offer an innovative service to pharmaceutical and medical device companies.

The use of RWE based on observational studies can inform stakeholders with essential data on the effectiveness of medicines and treatment patterns (standards of care), as well as providing data on cost-effectiveness for healthcare providers.

Dendrite's market leading RWE registry solution will be enhanced with our own analytical and medical writing expertise to help companies obtain powerful RWE data for regulatory bodies, publications, clinical engagement and for internal market analysis and planning. "It is a fundamental requirement for all healthcare providers to understand the real world impact of medicines and devices," said Dr Peter Walton, Managing Director, Dendrite Clinical Systems. "Our joint collaboration will help identify and interpret real-world outcomes. We are pleased to be working with Dianthus Medical on this collaboration."

Dendrite Clinical Systems is a world leader in database software for national and international registries, and hospitals. The company's client base extends across >250 hospitals and >90 national and international databases, in  over 40 different countries. To learn more about the company's products and services please visit: www.e-dendrite.com.

To find out more about how we can help you with your observational data needs, please contact us.